Effectiveness and tolerability of early initiation of combined lipid-lowering therapy included simvastatin and fenofibrate vs simvastatin alone in patients with acute coronary syndrome and type 2 diabetes mellitus with hypertriglyceridemia. UJC [Internet]. 2020 Jun. 11 [cited 2024 Nov. 21];27(2):34-45. Available from: https://ucardioj.com.ua/index.php/UJC/article/view/213